Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Choline for Prevention of TPN-Associated Hepatic Steatosis
NCT00031135Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Sep 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hepatic steatosis comparing Choline Chloride with Placebo (2 arms). Primary endpoint: Hepatic Steatosis Evaluation at 16 weeks. Started Sep 2001; status: terminated.
02
Drugs
choline chloride
03
Conditions
hepatic steatosis
Beyond the preview
Go deeper on NCT00031135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031135.